The first-line pharmacological treatment for major depressive disorder (MDD) are antidepressant drugs known as selective serotonin re-uptake inhibitors (SSRIs). But a significant proportion of people don't respond to these ...
Oct 24, 2023
0
3
Most folks know that certain antidepressants have to be taken for a few weeks before people start seeing improvement, and now a new study sheds light on that delay.
Oct 17, 2023
0
40
Researchers at The Florey and Austin Health have shown it is possible to detect tell-tale signs of Parkinson's disease 20–30 years before symptoms appear. Their work opens the door to screening programs and preventative ...
Oct 11, 2023
0
8
SSRI antidepressants normally take a few weeks before any showing mental health benefits, but how come it takes so long? Now a study from a group of clinicians and scientists provides the first human evidence that this is ...
Oct 9, 2023
0
3
For patients with giant cell arteritis (GCA), a higher total vascular score (TVS) based on 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging at diagnosis is associated with a greater increase in thoracic ...
Oct 3, 2023
0
51
The axial field of view (AFOV) plays a pivotal role in determining image quality in positron emission tomography (PET). While total-body PET scanners like the uEXPLORER offer superior sensitivity, they come at a higher cost ...
Sep 27, 2023
0
1
A common research tool used to measure brain inflammation and test new dementia drugs may not be as helpful as scientists had hoped.
Sep 25, 2023
0
102
A panel of 48 proteins in the cerebrospinal fluid (CSF 48 panel) complements existing CSF biomarkers for Alzheimer disease (AD), according to a study published in the Sept. 6 issue of Science Translational Medicine.
Sep 8, 2023
0
1
The surface protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), known as the spike protein, is critical for infecting host cells. The spike protein facilitates the infection process by binding to ...
Aug 30, 2023
0
11
Researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London have used a novel approach to show that the patterns of activity in two brain chemical systems—glutamate and serotonin—are ...
Aug 9, 2023
0
171
